Inducible receptors

L. F. Donaldson, M. R. Hanley, Amparo C Villablanca

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

While regulation of receptor function is known to occur at many levels (e.g. transcriptional, post-translational), it is generally perceived that a tissue either expresses or does not express a particular receptor in all-or- none fashion. Many pathological (e.g. tissue injury) and physiological (e.g. angiogenesis) processes have, however, been shown to be associated with the transcriptional induction of specific receptors. Induced receptors are not confined to any particular class, but range from G protein-coupled receptors to receptor tyrosine kinases. The potential implications of de novo receptor expression are profound with respect to potential novel therapeutic targets in specific disease states. Further, this observation may explain unexpected side-effects in the pharmacotherapy of existing disease states. In this article Lucy Donaldson, Michael Hanley and Amparo Villablanca discuss circumstances under which de novo receptor induction has been described, potential mechanisms of induction and the implications for pharmacology.

Original languageEnglish (US)
Pages (from-to)171-180
Number of pages10
JournalTrends in Pharmacological Sciences
Volume18
Issue number5
DOIs
StatePublished - May 1 1997

Fingerprint

Physiologic Neovascularization
Tissue
Drug therapy
Receptor Protein-Tyrosine Kinases
G-Protein-Coupled Receptors
Pharmacology
Drug Therapy
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Inducible receptors. / Donaldson, L. F.; Hanley, M. R.; Villablanca, Amparo C.

In: Trends in Pharmacological Sciences, Vol. 18, No. 5, 01.05.1997, p. 171-180.

Research output: Contribution to journalArticle

Donaldson, L. F. ; Hanley, M. R. ; Villablanca, Amparo C. / Inducible receptors. In: Trends in Pharmacological Sciences. 1997 ; Vol. 18, No. 5. pp. 171-180.
@article{5c0b56070dd94803872fc225fc42290a,
title = "Inducible receptors",
abstract = "While regulation of receptor function is known to occur at many levels (e.g. transcriptional, post-translational), it is generally perceived that a tissue either expresses or does not express a particular receptor in all-or- none fashion. Many pathological (e.g. tissue injury) and physiological (e.g. angiogenesis) processes have, however, been shown to be associated with the transcriptional induction of specific receptors. Induced receptors are not confined to any particular class, but range from G protein-coupled receptors to receptor tyrosine kinases. The potential implications of de novo receptor expression are profound with respect to potential novel therapeutic targets in specific disease states. Further, this observation may explain unexpected side-effects in the pharmacotherapy of existing disease states. In this article Lucy Donaldson, Michael Hanley and Amparo Villablanca discuss circumstances under which de novo receptor induction has been described, potential mechanisms of induction and the implications for pharmacology.",
author = "Donaldson, {L. F.} and Hanley, {M. R.} and Villablanca, {Amparo C}",
year = "1997",
month = "5",
day = "1",
doi = "10.1016/S0165-6147(97)01048-1",
language = "English (US)",
volume = "18",
pages = "171--180",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Inducible receptors

AU - Donaldson, L. F.

AU - Hanley, M. R.

AU - Villablanca, Amparo C

PY - 1997/5/1

Y1 - 1997/5/1

N2 - While regulation of receptor function is known to occur at many levels (e.g. transcriptional, post-translational), it is generally perceived that a tissue either expresses or does not express a particular receptor in all-or- none fashion. Many pathological (e.g. tissue injury) and physiological (e.g. angiogenesis) processes have, however, been shown to be associated with the transcriptional induction of specific receptors. Induced receptors are not confined to any particular class, but range from G protein-coupled receptors to receptor tyrosine kinases. The potential implications of de novo receptor expression are profound with respect to potential novel therapeutic targets in specific disease states. Further, this observation may explain unexpected side-effects in the pharmacotherapy of existing disease states. In this article Lucy Donaldson, Michael Hanley and Amparo Villablanca discuss circumstances under which de novo receptor induction has been described, potential mechanisms of induction and the implications for pharmacology.

AB - While regulation of receptor function is known to occur at many levels (e.g. transcriptional, post-translational), it is generally perceived that a tissue either expresses or does not express a particular receptor in all-or- none fashion. Many pathological (e.g. tissue injury) and physiological (e.g. angiogenesis) processes have, however, been shown to be associated with the transcriptional induction of specific receptors. Induced receptors are not confined to any particular class, but range from G protein-coupled receptors to receptor tyrosine kinases. The potential implications of de novo receptor expression are profound with respect to potential novel therapeutic targets in specific disease states. Further, this observation may explain unexpected side-effects in the pharmacotherapy of existing disease states. In this article Lucy Donaldson, Michael Hanley and Amparo Villablanca discuss circumstances under which de novo receptor induction has been described, potential mechanisms of induction and the implications for pharmacology.

UR - http://www.scopus.com/inward/record.url?scp=0030962516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030962516&partnerID=8YFLogxK

U2 - 10.1016/S0165-6147(97)01048-1

DO - 10.1016/S0165-6147(97)01048-1

M3 - Article

C2 - 9184478

AN - SCOPUS:0030962516

VL - 18

SP - 171

EP - 180

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 5

ER -